Notes And Other Explanatory Information [Abstract]

BioPorto - Filing #1379628

Concept 2022-01-01 to
2022-12-31
Notes and other explanatory information [abstract]
Disclosure of accounting judgements and estimates [text block]
Disclosure of accrued expenses and other liabilities [text block]
Disclosure of allowance for credit losses [text block]
Disclosure of auditors' remuneration [text block]
Disclosure of basis of consolidation [text block]
Disclosure of basis of preparation of financial statements [text block]
Disclosure of cash flow statement [text block]
Disclosure of changes in accounting policies [text block]
Disclosure of commitments [text block]
Disclosure of contingent liabilities [text block]
Disclosure of credit risk [text block]
Credit risk
Disclosure of deferred taxes [text block]
Disclosure of depreciation and amortisation expense [text block]
.
Disclosure of earnings per share [text block]
Disclosure of entity's operating segments [text block]
Disclosure of events after reporting period [text block]
Disclosure of finance cost [text block]
Disclosure of finance income [text block]
Disclosure of financial instruments [text block]
Disclosure of financial risk management [text block]
Disclosure of impairment of assets [text block]
Disclosure of income tax [text block]
Disclosure of information about employees [text block]
4. Staff costs
Disclosure of information about key management personnel [text block]
Disclosure of intangible assets [text block]
Disclosure of inventories [text block]
Disclosure of leases [text block]
Leases
Disclosure of property, plant and equipment [text block]
Disclosure of related party [text block]
Disclosure of research and development expense [text block]
Disclosure of revenue [text block]
Disclosure of share capital, reserves and other equity interest [text block]
Disclosure of share-based payment arrangements [text block]
.
Disclosure of tax receivables and payables [text block]
.
Disclosure of trade and other receivables [text block]
15. Receivables

Talk to a Data Expert

Have a question? We'll get back to you promptly.